A woman with hirsutism but otherwise symptom-free was found to have a raised serum prolactin and a pituitary microadenoma. The hyperprolactinaemia persisted despite bromocriptine therapy and subsequent pituitary surgery, which yielded a non-functioning adenoma. After a further 15 years with persistent hyperprolactinaemia but no symptoms, macroprolactinaemia was diagnosed. Such cases might account for part of the failure rate of pituitary microsurgery for prolactinoma. Testing for macroprolactinaemia is advisable in a woman with hyperprolactinaemia, especially if her ovulatory cycle is normal. Two other cases are reported in which macroprolactinaemia was associated with menstrual disturbances and other hormonal effects: in these, treatment with dopamine agonists suppressed the hyperprolactinaemia and restored normal menstrual cycles.
INTRODUCTION
Prolactin (PRL) exists in multiple forms of different molecular sizes. The predominant species is monomeric (molecular weight 22kDa) and makes up about 95% of circulating prolactin while the remainder consists of larger molecular weight forms-'big' (50-60kDa) and 'big-big' (> 100kDa)',2. However, in some individuals the predominant prolactin form is the 'big-big', a phenomenon that has been termed 'macroprolactinaemia' and which is associated with hyperprolactinaemia3'4. Macroprolactin is largely a complex formed by the binding of monomeric PRL to immunoglobulin (IgG)S-7, and the presence of macroprolactinaemia can be established by subjecting serum to gel filtration chromatography or the polyethylene glycol precipitation test8. Macroprolactinaemia has been reported mainly as a cause of idiopathic hyperprolactinaemia, in patients without imaging evidence of a pituitary lesion3'9' I0 Here we report a case of hyperprolactinaemia that was initially thought to be due to a prolactin-secreting microadenoma. Two other cases are described to illustrate the clinical spectrum of the condition.
METHODS
The polyethylene glycol precipitation test with assessment of percentage of prolactin recovery and gel filtration chromatography were performed as previously described8.
Prolactin concentrations were measured in serum, in fractions from gel filtration chromatography and in the supernatant obtained after polyethylene glycol precipitation by the DELFIA solid-phase fluoroimmunoassay. A serum sample was classified as being macroprolactin-positive when prolactin recovery was less than or equal to 40% or when the proportion of macroprolactin present, as determined by analysis of area under the prolactin curve during gel filtration chromatography, was equal to or greater than 30%8.
CASE HISTORIES

Case I
A married and fertile woman aged 31 sought advice for hirsutism. The only noteworthy hormonal abnormality was her serum prolactin, raised at 1700mU/L. She had no menstrual disturbances or galactorrhoea but a computed tomographic (CT) scan of the pituitary showed a small adenoma confined to the fossa. A left upper temporal visual field defect was noted (and was never explained). She was initially treated with a dopamine agonist, bromocriptine, but this did not adequately control serum prolactin. Subsequently a histologically proven small adenoma was removed by trans-sphenoidal surgery. This was immunoperoxidase-negative for all the pituitary hormones. Postoperatively her serum prolactin remained high at 3610 mU/L. Over the next 6 years, without dopamine agonist treatment, prolactin concentrations fluctuated between 1200 and 2000mU/L but she had no menstrual irregularity or galactorrhoea. Two further CT scans and a magnetic resonance scan of the pituitary showed no evidence of tumour recurrence. 15 her serum (macroprolactin 79%) and a polyethylene glycol precipitation test (prolactin recovery 12.6%) were positive for macroprolactinaemia. Case 2 This patient was referred at age 19 because of secondary amenorrhoea. Her menstrual cycle had always been regular and she had never been pregnant. The only hormonal abnormality was a persistently raised prolactin of 950 mU/L. A CT scan of the pituitary was normal. Treatment with bromocriptine suppressed serum prolactin and restored regular menses. 7 years into treatment she became pregnant and was delivered of a normal baby. A repeat CT scan showed a normal pituitary. Every attempt to discontinue bromocriptine resulted in rebound hyperprolactinaemia. 18 years after she was first seen, gel filtration chromatography of her serum (macroprolactin 34%) and a polyethylene glycol precipitation test (prolactin recovery 37%) revealed macroprolactinaemia.
Case 3
A mother of two children was referred at age 35 with a 15-year history of mild facial hirsutism and recent onset menstrual irregularity and galactorrhoea. There was no virilization. Serum prolactin was raised at 3200 mU/L and the androgen profile showed mildly raised testosterone and androgen levels. Basal serum cortisol was normal as were the basal and stimulated 17-hydroxyprogesterone concentrations. Ultrasound scan of the pelvis showed polycystic ovaries. A CT scan of the pituitary was normal. Hirsutism was controlled by electrolysis while treatment with the dopamine agonist quinagolide restored serum prolactin to normal; menses became regular and galactorrhoea also settled. Stoppage of dopamine agonist therapy always led to a rise in serum prolactin. Gel filtration chromatography of her serum (macroprolactin 93%) and a polyethylene glycol precipitation test (prolactin recovery 6.2%) performed when she was 43 were positive for macroprolactinaemia. DISCUSSION Initially, the hyperprolactinaemia in patient 1 was thought to be due to her pituitary adenoma. That the cause was macroprolactinaemia became evident only when the adenoma proved to be non-functioning, when the prolactin remained high after operation and when other causes of hyperprolactinaemia had been excluded. This case adds to the evidence for macroprolactinaemia as a distinct cause of hyperprolactinaemia3'4,9'10. To our knowledge, this is the first report of a non-functioning pituitary adenoma coexisting with macroprolactinaemia. Macroprolactinaemia caused this patient's non-functioning adenoma to be labelled inappropriately as a prolactin-secreting tumour. Even if imaging of the pituitary had been equivocal or negative, a clinician might still have suspected an 'occult' microprolactinoma or lactotroph hyperplasia rather than macroprolactinaemia as the cause of the persistent raised prolactin. Furthermore, as illustrated by this case, macroprolactinaemia may also confound the apparent success rate (i.e. normalization of serum prolactin and amelioration of symptoms) achieved with surgical treatment for microprolactinomas; some of the failures seen with microsurgery (defined as persistent hyperprolactinaemia postoperatively) could be accounted for by unrecognized coexisting macroprolactinaemia. Testing for macroprolactinaemia is thus an important part of the investigation of hyperprolactinaemia, particularly if the ovulatory cycle is normal.
What are the symptoms of macroprolactinaemia? In some patients the usual effects of a raised prolactin are absent3'9' 10, raising the speculation that macroprolactin has lower bioactivity in vivo than prolactin. This suggestion fits with the clinical picture in patient 1, in whom hyperprolactinaemia was discovered fortuitously and there were never any symptoms ascribable to the hormonal excess (i.e. menstrual disturbances, galactorrhoea or infertility). However, some patients with macroprolactinaemia do experience symptoms of hyperprolactinaemia5'7 as illustrated by cases 2 and 3. The fact that patient 1 had 79% macroprolactin without symptoms and patient 2 had only 34% macroprolactin with symptoms mirrors the conflicting results from in vitro bioactivity studies56'1 1. The reason why some individuals with macroprolactinaemia are symptomatic while others are not remains unclear. The evidence from cases 2 and 3 suggests that dopamine agonists will sometimes control both prolactin concentrations and symptoms. year-old labourer who the day before had been kicked on the head by a horse. There was no loss of consciousness. Broca found a 6-7 cm cut in the left frontoparietal region. No fracture was evident and the cut was cleaned. The wound seemed to heal well until 11 July when signs of erysipelas were evident. This settled by 24 July and the patient was treated for an arterial haemorrhage. On 22 July the patient had headaches and fever and manifested a nonfluent aphasia, with progressive stupor, right-sided paralysis and facial paralysis. He became deeply comatose on 27 July. Broca suspected an intracranial abscess on the left side and localized it to the language area in the left third frontal gyrus, on account of the aphasia. He performed a craniotomy, draining epidural pus about 'the volume of a pigeon's egg'. From the gravity of the symptoms Broca suspected further disease. The patient improved transiently but died on 29 July. Necropsy revealed an extensive predominantly frontal left purulent meningoencephalitis.
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